← Evidence map

ArticlePloS one2025

A real-world pharmacovigilance analysis of ALK inhibitor-associated pleural and pericardial effusion using the FDA Adverse Events Reporting System (FAERS) database from 2013 to 2024.

Connor FreyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

A real-world pharmacovigilance analysis of ALK inhibitor-associated pleural and pericardial effusion using the FDA Adverse Events Reporting System (FAERS) database from 2013 to 2024. | OpenQuestion